321 related articles for article (PubMed ID: 18835883)
21. Upregulated expression of substance P and NK1R in blood monocytes and B cells of patients with allergic rhinitis and asthma.
Han P; Chen L; Chen D; Yang R; Wang W; Liu J; He S; Zhang H
Clin Exp Immunol; 2022 Oct; 210(1):39-52. PubMed ID: 36001730
[TBL] [Abstract][Full Text] [Related]
22. SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant.
Ebrahimi S; Mirzavi F; Aghaee-Bakhtiari SH; Hashemy SI
Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119221. PubMed ID: 35134443
[TBL] [Abstract][Full Text] [Related]
23. Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.
Koh YH; Moochhala S; Bhatia M
J Cell Mol Med; 2012 Jul; 16(7):1582-92. PubMed ID: 22040127
[TBL] [Abstract][Full Text] [Related]
24. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.
Szabo I; Wetzel MA; Zhang N; Steele AD; Kaminsky DE; Chen C; Liu-Chen LY; Bednar F; Henderson EE; Howard OM; Oppenheim JJ; Rogers TJ
J Leukoc Biol; 2003 Dec; 74(6):1074-82. PubMed ID: 12972507
[TBL] [Abstract][Full Text] [Related]
25. Extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells.
Koh YH; Tamizhselvi R; Bhatia M
J Pharmacol Exp Ther; 2010 Mar; 332(3):940-8. PubMed ID: 20007404
[TBL] [Abstract][Full Text] [Related]
26. Role of protein kinase C and phosphoinositide 3-kinase-Akt in substance P-induced proinflammatory pathways in mouse macrophages.
Sun J; Ramnath RD; Tamizhselvi R; Bhatia M
FASEB J; 2009 Apr; 23(4):997-1010. PubMed ID: 19029199
[TBL] [Abstract][Full Text] [Related]
27. Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor.
Schmidlin F; Dery O; DeFea KO; Slice L; Patierno S; Sternini C; Grady EF; Bunnett NW
J Biol Chem; 2001 Jul; 276(27):25427-37. PubMed ID: 11306580
[TBL] [Abstract][Full Text] [Related]
28. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.
Lai JP; Ho WZ; Zhan GX; Yi Y; Collman RG; Douglas SD
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3970-5. PubMed ID: 11274418
[TBL] [Abstract][Full Text] [Related]
29. Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism.
Meshki J; Douglas SD; Lai JP; Schwartz L; Kilpatrick LE; Tuluc F
J Biol Chem; 2009 Apr; 284(14):9280-9. PubMed ID: 19179340
[TBL] [Abstract][Full Text] [Related]
30. Substance P and the Neurokinin-1 Receptor: The New CRF.
Schank JR; Heilig M
Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
[TBL] [Abstract][Full Text] [Related]
31. New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
Ebrahimi S; Javid H; Alaei A; Hashemy SI
Clin Genet; 2020 Oct; 98(4):322-330. PubMed ID: 32266968
[TBL] [Abstract][Full Text] [Related]
32. The third intracellular loop and carboxyl tail of neurokinin 1 and 3 receptors determine interactions with beta-arrestins.
Schmidlin F; Roosterman D; Bunnett NW
Am J Physiol Cell Physiol; 2003 Oct; 285(4):C945-58. PubMed ID: 12958028
[TBL] [Abstract][Full Text] [Related]
33. Substance P enhances microglial density in the substantia nigra through neurokinin-1 receptor/NADPH oxidase-mediated chemotaxis in mice.
Wang Q; Oyarzabal E; Wilson B; Qian L; Hong JS
Clin Sci (Lond); 2015 Oct; 129(8):757-67. PubMed ID: 26223840
[TBL] [Abstract][Full Text] [Related]
34. Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK
Zhong W; Chebolu S; Darmani NA
Neurochem Int; 2019 Jan; 122():106-119. PubMed ID: 30453005
[TBL] [Abstract][Full Text] [Related]
35. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses.
Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI
Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877
[TBL] [Abstract][Full Text] [Related]
36. Neurokinin 1 receptor isoforms and the control of innate immunity.
Tuluc F; Lai JP; Kilpatrick LE; Evans DL; Douglas SD
Trends Immunol; 2009 Jun; 30(6):271-6. PubMed ID: 19427266
[TBL] [Abstract][Full Text] [Related]
37. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells.
Ruffing N; Sullivan N; Sharmeen L; Sodroski J; Wu L
Cell Immunol; 1998 Nov; 189(2):160-8. PubMed ID: 9790730
[TBL] [Abstract][Full Text] [Related]
38. Anti-infective peptide IDR-1002 augments monocyte chemotaxis towards CCR5 chemokines.
Madera L; Hancock RE
Biochem Biophys Res Commun; 2015 Aug; 464(3):800-6. PubMed ID: 26168734
[TBL] [Abstract][Full Text] [Related]
39. Selective G protein signaling driven by substance P-neurokinin receptor dynamics.
Harris JA; Faust B; Gondin AB; Dämgen MA; Suomivuori CM; Veldhuis NA; Cheng Y; Dror RO; Thal DM; Manglik A
Nat Chem Biol; 2022 Jan; 18(1):109-115. PubMed ID: 34711980
[TBL] [Abstract][Full Text] [Related]
40. The neuropeptide substance P is a critical mediator of burn-induced acute lung injury.
Sio SW; Puthia MK; Lu J; Moochhala S; Bhatia M
J Immunol; 2008 Jun; 180(12):8333-41. PubMed ID: 18523300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
